Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Dr Esmaeil Mehraeen, Khalkhal University of Medical Sciences, Iran

Dr. Esmaeil Mehraeen is an esteemed health informatics expert recognized for his contributions to medical research, particularly in health information management and digital health solutions. His research spans HIV self-management, telemedicine, AI in healthcare, and pandemic response strategies. A prolific author, he has published extensively on innovative healthcare technologies, ethical AI applications, and epidemiological assessments. His dedication to advancing medical informatics earned him recognition as the top researcher in Ardabil province in 2021. With a strong academic and executive background, he continues to shape the future of health informatics, making him an ideal candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Esmaeil Mehraeen is a dedicated expert in Health Information Management πŸ“ŠπŸ©Ί, earning his Ph.D. from Tehran University of Medical Sciences (2015-2018). His doctoral research focused on designing, developing, and evaluating a mobile and web-based intelligent self-management system for people living with HIV πŸ“±πŸ’‘. He previously completed an MSc in Medical Records Education (2010-2012) at the same university, where he explored information security in hospital information systems at Tehran and Shahid Beheshti Universities πŸ₯πŸ”. His academic journey began with a BSc in Medical Records (2005-2007) from Shahid Beheshti University of Medical Sciences πŸ“‘πŸ“š, laying the foundation for his expertise in health data management and security. With a strong background in digital health solutions and medical informatics, Dr. Mehraeen contributes to improving healthcare technology and patient self-management systems πŸ₯πŸ“². His work bridges the gap between healthcare and innovative digital tools, ensuring secure and efficient health information management πŸ”πŸ’».

Experience

Dr. Esmaeil Mehraeen is a dedicated academic and researcher in medical sciences πŸ₯πŸ“š. He has served as a Faculty Member at Khalkhal University of Medical Sciences (2018-2024) πŸ‘¨β€πŸ« and previously held the same role at Zabol University of Medical Sciences (2012-2015) and Ardabil University of Medical Sciences (2016-2018) πŸŽ“πŸ“–. His leadership roles include serving as Vice President of Education & Research at Khalkhal University (2019-2021) πŸ“ŠπŸ›, where he contributed to advancing academic programs. Additionally, he was Student Manager (2018-2019) πŸŽ“πŸ“‹ and Head of the Scientometric Department (2018) πŸ”πŸ“ˆ. Dr. Mehraeen has been an active Research & Educational Council Member across various universities in Iran πŸ“ŠπŸ”¬πŸ“š, fostering scientific collaboration and innovation. His extensive experience in medical education, research leadership, and scientometrics highlights his commitment to academic excellence and the advancement of healthcare sciences πŸ“–πŸ”¬πŸ₯.

Awards & Honors

Dr. Esmaeil Mehraeen is a distinguished researcher recognized as the Top Researcher in Ardabil Province (2021) πŸ†πŸŽ– for his outstanding contributions. His academic excellence began early, securing 1st place in the Ph.D. Entrance Exam (2015) πŸ₯‡πŸ“š and being honored as an Exemplary Student in his MSc Program (2011) πŸŽ“πŸ…. His dedication to research and education is evident through his active role as a member of Research & Educational Councils (2010-2021) πŸ›πŸ“–, shaping academic policies and fostering innovation. Additionally, he played a key role in student research, serving as a member of the Student Research Committee at Iran University of Medical Sciences (2010-2011) πŸ”¬πŸ‘¨β€πŸ”¬πŸ“š, contributing significantly to medical advancements. His commitment to academic excellence and research leadership continues to inspire students and scholars alike. πŸŒŸπŸ“–

Research Focus

Dr. Esmaeil Mehraeen is a dedicated expert in health information management, medical informatics, and digital health solutions. πŸ₯πŸ’» His research spans AI-driven chatbots in healthcare πŸ€–πŸ₯, telemedicine innovations πŸ“‘πŸ“ž, and self-management systems for HIV patients πŸ₯πŸ“². He has contributed significantly to epidemiological studies on COVID-19 πŸ¦ πŸ“Š, providing valuable insights into public health responses. His work also delves into ethical considerations in AI healthcare applications βš–οΈπŸ€–, health system security πŸ”, and data-driven decision-making in public health πŸ“ŠπŸŒ. Through systematic reviews and meta-analyses πŸ“šπŸ”, Dr. Mehraeen influences global health informatics research, shaping policies and advancing medical technologies. His interdisciplinary approach fosters innovation, improving healthcare accessibility and efficiency worldwide. πŸŒπŸ’‘πŸ‘¨β€πŸ”¬

Publication Top Notes

Predictors of mortality in patients with COVID-19–a systematic review

Late complications of COVID-19; a systematic review of current evidence

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence

The relationship between COVID‐19 viral load and disease severity: A systematic review

The challenges of E‑learning system: Higher educational institutions perspective

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Post-synthetic functionalization of the metal-organic framework: Clean synthesis, pollutant removal, and antibacterial activity

 

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications πŸ“„ and supervised doctoral candidates πŸŽ“, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors πŸ₯. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology πŸ”¬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes πŸ₯.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology πŸ… from the University Hospital of DΓΌsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology πŸ“– from the University of DΓΌsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice πŸ§ͺ. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of DΓΌsseldorf (1983). His expertise in cancer biology, virology, and molecular research πŸ“Š has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine πŸ”¬πŸ’Š. He is currently a Senior Postdoctoral Fellow at the Institut National de la SantΓ© et de la Recherche MΓ©dicale, University of Strasbourg, France (2018-2025) πŸ₯. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) πŸŽ“, and a Postdoctoral Fellow at the University Hospital of DΓΌsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion πŸ₯, and targeting cancer stem-like cells to enhance treatment efficacy πŸ’Š. He investigates the role of non-receptor tyrosine kinases in oncogenesis πŸ”¬ and explores immune checkpoint inhibitors and their associated cutaneous adverse effects βš•οΈ. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-ΞΊB Pathways

 

 

 

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Mr WEN CHANG TSENG, Cathay General Hospital/Departmentof Radiology, Taiwan

Mr. Wen Chang Tseng is an accomplished medical radiologic technologist and deputy director with extensive expertise in diagnostic radiology and clinical trials. πŸ“‘πŸ”¬ With a career spanning over two decades (since 1999), he has contributed significantly to medical imaging and radiology, playing a key role in multinational clinical trials on ankylosing spondylitis and rheumatoid arthritis. πŸ₯ His work in advancing radiological technology has made a substantial impact in medical research, ensuring high standards in diagnostic procedures. 🎯 His dedication to improving patient care through innovative imaging techniques and clinical studies has earned him recognition as a leading expert in his field. 🌍 His contributions to Phase II and Phase III multinational studies highlight his commitment to advancing diagnostic radiology. πŸ“ˆ His leadership in technology development, combined with his research experience, makes him a deserving recipient of the Best Researcher Award. πŸ…πŸ‘

Publication Profile

Scopus

Education

Mr. Wen Chang Tseng holds a strong educational background in medical imaging and engineering. πŸ›οΈ He earned his degree from the Department of Medical Imaging and Radiological Technology at Yuanpei University, where he gained in-depth knowledge of radiological sciences and medical imaging techniques. πŸ₯πŸ” Expanding his technical expertise, he further pursued studies in the Department of Electrical Engineering at Chung Yuan Christian University, enhancing his understanding of technological applications in medical diagnostics. ⚑πŸ–₯️ His combined knowledge of radiology and electrical engineering allows him to develop and implement cutting-edge imaging solutions for enhanced patient diagnosis and treatment. πŸ† His education has provided a robust foundation for his career in medical radiology, clinical trials, and diagnostic imaging research. 🎯 His multidisciplinary academic training continues to support his innovative contributions to medical technology and radiology advancements. πŸ“‘πŸ©»

Experience

With over two decades of experience in the field of diagnostic radiology, Mr. Wen Chang Tseng has been a cornerstone of medical imaging and radiologic technology. πŸ† Since 1999, he has been actively involved in the Diagnostic Radiology Department, applying his expertise in radiological imaging to enhance diagnostic accuracy. πŸ₯ His dedication and leadership have led him to serve as a Medical Radiologic Technologist and Deputy Director of Technology, where he has played a pivotal role in managing radiological procedures, research coordination, and advanced imaging technologies. πŸ”¬πŸ–₯️ His work extends to supervising and conducting multinational clinical trials focusing on ankylosing spondylitis and rheumatoid arthritis. πŸŒŽπŸ“Š His contributions have improved clinical imaging protocols and enhanced the reliability of diagnostic techniques. 🎯 His leadership in medical imaging research and development has made a lasting impact on the field of radiology. πŸ…πŸ‘

Awards & Honors

Mr. Wen Chang Tseng’s contributions to medical imaging and radiological technology have been widely recognized through numerous accolades. πŸ† His expertise in diagnostic radiology and clinical trial research has earned him prestigious honors, including commendations for excellence in radiologic innovation and clinical research advancements. 🌟 As a leader in medical imaging research, he has been an integral part of groundbreaking Phase II and Phase III multinational studies on ankylosing spondylitis and rheumatoid arthritis. πŸ“ˆ His pioneering role in clinical trials has led to significant improvements in diagnostic imaging standards, contributing to global advancements in radiology. 🌍 He has also been acknowledged by international research institutions for his commitment to technological advancements in radiologic sciences. πŸ”¬ His dedication and innovation make him a distinguished figure in the field, making him a deserving recipient of the Best Researcher Award. πŸ…πŸŽ―

Research Focus

Mr. Wen Chang Tseng specializes in diagnostic radiology, medical imaging technology, and clinical trial research. πŸ“‘ His work focuses on enhancing imaging techniques for ankylosing spondylitis and rheumatoid arthritis through Phase II and Phase III multinational clinical trials. πŸ₯ He has played a crucial role in advancing radiologic assessment methods, ensuring precise imaging for improved diagnosis and treatment planning. 🎯 His research integrates medical imaging with electrical engineering, allowing for the development of cutting-edge radiologic technologies. πŸ–₯️⚑ His contributions to clinical trials have led to refined imaging protocols, benefiting global healthcare standards. 🌍 His multidisciplinary expertise in radiology and technology has driven innovation in diagnostic procedures, improving efficiency and accuracy in detecting musculoskeletal disorders. πŸ“Š His research continues to shape the future of medical imaging, contributing to better patient care and medical advancements. πŸ†

Publication Top Notes

Assessing the seasonality of occupancy number-associated CO2Β level in a Taiwan hospital